Researchers at Karolinska Institutet in Sweden have found that type IgG antibodies play an unexpected role in atherosclerosis. A study on mice shows that the antibodies stabilize the plaque that accumulates on the artery walls, which reduces the risk of it rupturing and causing a blood clot. It is hoped that the results, which are […]Continue Reading ...
WEDNESDAY, Feb. 6, 2019 — Treatment of psoriasis with biologic therapy is associated with a reduction in noncalcified coronary plaque and improved plaque morphology, according to a study published online Feb. 5 in Cardiovascular Research. Youssef A. Elnabawi, from the National Institutes of Health in Bethesda, Maryland, and colleagues recruited 290 participants from Jan. 1, […]Continue Reading ...
Atherosclerosis, involving the buildup of plaque in the arteries and an associated reduction in the flow of blood, is a major feature of cardiovascular diseases. Although advances have been made in characterizing how this buildup occurs and ways to reduce it, diseases linked to atherosclerosis are still a major cause of mortality. In a major […]Continue Reading ...
— Gum disease may include symptoms from swollen gums to bad breath and loose or sensitive teeth. Gum disease starts with a buildup of bacteria in the mouth. Tiny microbes combine with mucus and other particles to form plaque on the teeth and gumline. Brushing and flossing will get rid of some plaque, but if […]Continue Reading ...
May 3, 2018 Researchers at Western University and Lawson Health Research Institute have shown a novel relationship between the intestinal microbiome and atherosclerosis, one of the major causes of heart attack and stroke. This was measured as the burden of plaque in the carotid arteries. In order to understand the role that bacteria in the […]Continue Reading ...
FDA Approves Ilumya (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis MUMBAI, India and PRINCETON, N.J., March 21, 2018 /PRNewswire/ — Sun Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or […]Continue Reading ...
March eight, 2017 Historic DNA discovered within the dental plaque of Neandertals – our nearest extinct relative – has equipped outstanding new insights into their behaviour, vitamin and evolutionary historical past, together with their use of plant-based drugs to regard ache and sickness. Printed nowadays within the magazine Nature, a global workforce led by way […]Continue Reading ...
A brand new computational modeling methodology may point out when atherosclerotic plaques will most probably go through fast expansion, reviews a find out about revealed in PLOS Computational Biology. Atherosclerosis is a type of vascular illness that may end up in center assaults, strokes and gangrene by way of inflicting the thickening of artery partitions […]Continue Reading ...
Credit: CC0 Public Domain An international collaboration jointly led by University College Dublin (UCD) and Monash University in Melbourne has found that mimicking the activity of molecules found naturally in the body may provide a new approach to treating vascular disease in diabetes. Diabetes presents an enormous global health challenge. Currently 425 million people have […]Continue Reading ...
August 17, 2018 When the good and bad bacteria in our mouth become imbalanced, the bad bacteria form a biofilm (aka plaque), which can cause cavities, and if left untreated over time, can lead to cardiovascular and other inflammatory diseases like diabetes and bacterial pneumonia. A team of researchers from the University of Illinois has […]Continue Reading ...
risankizumab Treatment for Plaque Psoriasis, Crohn’s Disease — Maintenance, Psoriatic Arthritis AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis NORTH CHICAGO, Ill., April 25, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it has submitted a Biologics License Application (BLA) […]Continue Reading ...
April 26, 2018 Late-breaking clinical science shows common therapy options for psoriasis (PSO)-a chronic inflammatory skin disease-can help reduce coronary plaque. The authors found that not only do the treatments reduce the volume of the plaque, but also the plaque becomes less inflammatory over time harboring fewer characteristics prone to rupture and cause a heart […]Continue Reading ...
October 3, 2017 To win the battle against heart disease, cardiologists need better ways to identify the composition of plaque most likely to rupture and cause a heart attack. Angiography allows them to examine blood vessels for constricted regions by injecting them with a contrast agent before X-raying them. But because plaque does not always […]Continue Reading ...
Janssen Pronounces FDA Approval of Tremfya (guselkumab) for the Remedy of Average to Critical Plaque Psoriasis Horsham, PA, July 13, 2017 ― Janssen Biotech, Inc. (Janssen) introduced nowadays that the U.S. Meals and Drug Management (FDA) has licensed Tremfya (guselkumab) for the remedy of adults dwelling with reasonable to serious plaque psoriasis who’re applicants for […]Continue Reading ...
Motion Issues Observe that this observational learn about means that plaque protrusion all through carotid stenting poses a top chance for next stroke. Bear in mind that handiest nine sufferers on this learn about had plaque protrusion, proscribing the precision of estimates of impact. Having plaque creep into the lumen of the stent all through […]Continue Reading ...
- Smart assistants could help combat opioid crisis
- Diagnostic stewardship strategy reduces inappropriate testing
- Three-antibiotic cocktail eradicates ‘persister’ Lyme bacteria in mouse model
- Study investigates how early blindness shapes sound processing
- Outcomes Worse for Cancer Patients Seen at Noncancer EDs
- Link found between temperament of high-risk infants and obesity
- Al Letson explores ties between journalists and doctors at Medicine and the Muse symposium
- New mobile phone game can detect people at risk of Alzheimer’s
- Exercise activates brain circuits associated with memory in older adults
- Veggies, Fruits and Grains Keep Your Heart Pumping
- Healthy meal kits can boost children’s long-term health
- Designing an inexpensive surgical headlight: A Q&A with a Stanford surgeon
- States Weigh Banning A Widely Used Pesticide Even Though EPA Won’t
- Integrator complex proteins are crucial for healthy brain development in fruit flies, study finds
- Device converts brain signals into speech, offering hope for patients
- Measles vaccination rates are a ‘public health time bomb’
- Maths made easier for scientists students who shun the subject wins award
- Researchers decode how cancer drug works in brains of Parkinson’s disease patients
- Smarter Brain Cancer Trial Comes to Columbia
- Researchers Seek Sage Advice Of Elders On Aging Issues